Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 19, 2025
Clinical, Obstetric-Gynaecological and HRQoL Data of Female VWD Patients in the WIL-QoL StudySusan Halimeh, Cornelia Wermes, Carolin Moorthi, et al.
Endocrine Connections|October 25, 2023
Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trialsJulia Beckhaus, Svenja Boekhoff, Katrin Scheinemann, et al.
Neuropeptides|June 10, 2005
Galanin and galanin receptors in human cancersAlexandra Berger, Radmila Santic, Cornelia Hauser-Kronberger, et al.
BMC Cancer|April 20, 2010
Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastomaRene' G Feichtinger, Franz Zimmermann, Johannes A Mayr, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 28, 2020
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia AJayashree Motwani, Benoit Guillet, Jan Blatny, et al.
Journal of Molecular Neuroscience : MN|September 7, 2006
Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide geneRadmila Santic, Katrin Fenninger, Kerstin Graf, et al.
The New England Journal of Medicine|April 5, 2002
Neuroblastoma screening at one year of ageFreimut H Schilling, Claudia Spix, Frank Berthold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97Barbara Hero, Thorsten Simon, Ruediger Spitz, et al.
Pediatric Blood & Cancer|April 7, 2021
Clinical and molecular characterization of patients with stage 4(M) neuroblastoma aged less than 18 months without MYCN amplificationFrank Berthold, Carolina Rosswog, Holger Christiansen, et al.
Pageof 3